Distribution of acquired carbapenemase genes among uropathogenic Escherichia coli
Naunyn-Schmiedeberg's Archives of Pharmacology · 2026-02 · 399 (3) · 3477-3494
DOI: 10.1007/s00210-025-04643-5 ↗Kurz gefasst
Fachartikel in der Zeitschrift Naunyn-Schmiedeberg's Archives of Pharmacology, online erschienen am 30.09.2025. Verfasst von Shervindokht Ahmadi und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Microbiology, ShQ.C., Islamic Azad University, Shahr-E Qods, Iran. Hauptthemen laut MEDLINE: beta-Lactamases, Uropathogenic Escherichia coli, Bacterial Proteins, Urinary Tract Infections. Die Arbeit wurde bisher 12-mal zitiert (Crossref) und nennt 98 Literaturangaben.
Abstract (Originalsprache)
PURPOSE: Antibacterial resistance (ABR) and the dissemination of acquired resistance genes (ARGs), particularly acquired carbapenemase genes (ACGs), have intensified the burden of difficult-to-treat infections such as urinary tract infections (UTIs). This study aimed to determine the prevalence of key ACGs, including blaDIM, blaGIM, blaIMP, blaNDM, blaSIM, blaSPM, blaVIM, blaAIM, blaBIC, blaKPC, and blaOXA-48, and to establish gene distribution profiles among uropathogenic Escherichia coli (UPEC) strains. METHODS: A total of 105 UPEC-positive urine samples were collected between August 2023 and January 2024. Isolates were confirmed using standard microbiological and biochemical methods. Antibacterial susceptibility testing (AST) was performed via the Kirby-Bauer disc diffusion method. The presence of ACGs was assessed by polymerase chain reaction (PCR), and results were analyzed using chi-square and Fisher's exact tests. RESULTS: Resistance and gene distribution profiles were established, including multidrug-resistant (MDR), extensively drug-resistant (XDR), and pandrug-resistant (PDR) patterns. The most prevalent ACGs were, respectively, blaSPM (82.86%), blaGIM (20.00%) and blaVIM (16.19%). Nine isolates (8.57%) lacked ACGs, while the blaSPM profile was predominant in 37 isolates (35.24%) and strongly associated with the highest ABR rates. Extended-spectrum β-lactamase (ESBL) production was detected in 38 isolates (36.19%). Overall, 75.24% of strains were MDR, 7.62% XDR, and 0.95% PDR. CONCLUSION: The high prevalence of ACGs, e.g., blaSPM and the rise of MDR, XDR, and PDR strains underscore the urgent need to reassess treatment strategies for UTIs. Novel therapeutic approaches and strategies are essential to control and reduce further resistance development.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Microbiology, ShQ.C., Islamic Azad University, Shahr-E Qods, Iran.
- Department of Microbiology, ShQ.C., Islamic Azad University, Shahr-E Qods, Iran. behzadipayam@yahoo.com.
Zitieren
APA
Ahmadi, S., Foroohi, F., Shirzadian, M., Vosoughi, A. F., Golpasand, T., & Behzadi, P. (2026). Distribution of acquired carbapenemase genes among uropathogenic Escherichia coli. Naunyn-Schmiedeberg's Archives of Pharmacology, 399(3), 3477-3494. https://doi.org/10.1007/s00210-025-04643-5
Vancouver
Ahmadi S, Foroohi F, Shirzadian M, Vosoughi AF, Golpasand T, Behzadi P. Distribution of acquired carbapenemase genes among uropathogenic Escherichia coli. Naunyn-Schmiedeberg's Archives of Pharmacology. 2026;399(3):3477-3494. doi:10.1007/s00210-025-04643-5
BibTeX
@article{Ahmadi2026,
author = {Ahmadi, Shervindokht and Foroohi, Fatemeh and Shirzadian, Maryam and Vosoughi, Abbas Fallah and Golpasand, Taha and Behzadi, Payam},
title = {Distribution of acquired carbapenemase genes among uropathogenic Escherichia coli},
journal = {Naunyn-Schmiedeberg's Archives of Pharmacology},
year = {2026},
volume = {399},
number = {3},
pages = {3477--3494},
doi = {10.1007/s00210-025-04643-5}
}
EUVIMED